Mie University · Graduate School of Medical Sciences · 教授

Research keywords治療開発・悪性リンパ腫・病態研究・リンパ腫・臨床試験

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Sawaki A, Miyazaki K, Yamaguchi M, et al. Genetic polymorphisms and vincristine-induced peripheral neuropathy in patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone therapy. Int J Hematol 111: 686-91, 20202020 · 主な業績等
• Shimada K, Yamaguchi M, et al. Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial. Lancet Oncol 21: 593-602, 20202020 · 主な業績等
• Miyazaki K, .., Yamaguchi M. DA-EPOCH-R combined with high-dose methotrexate in patients with newly diagnosed stage II-IV CD5-positive diffuse large B-cell lymphoma: a single-arm, open-label, phase 2 study. Haematologica 105: 2308-15, 20202020 · 主な業績等
• Yamaguchi M, et al. Improved prognosis of extranodal NK/T-cell lymphoma, nasal type of nasal origin but not extranasal origin. Ann Hematol 98: 1647-55, 20192019 · 主な業績等

• NK/T細胞リンパ腫の国際間病態比較と治療の最適化
• びまん性大細胞型Ｂ細胞リンパ腫の新規難治性病型に対する治療研究
• びまん性大細胞型Ｂ細胞リンパ腫の新規難治性病型に対する治療研究
• 中枢神経系再発高リスクの未治療びまん性大細胞型B細胞リンパ腫に対する中枢神経系再発予防を組み入れた治療法のランダム化第III相試験

• Official profile